financetom
Business
financetom
/
Business
/
Update: i3 Energy Proposes Reduction of Share Capital; Down 2% in LSE Trading
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: i3 Energy Proposes Reduction of Share Capital; Down 2% in LSE Trading
Mar 26, 2024 11:33 AM

02:00 PM EDT, 03/26/2024 (MT Newswires) -- i3 Energy plc ( ITEEF ) , an independent oil and gas company with assets and operations in the UK and Canada, earlier Tuesday said that it plans to reduce share capital to ensure there are sufficient distributable reserves to facilitate dividend payments in the long term.

The capital reduction process is not required to facilitate the payment of the next quarterly dividend, the company said.

The company has proposed that the amount standing to the credit of the transition reserve of about 148.5 million British pounds is capitalized through a bonus issue of newly created capital reduction shares with a nominal value of 0.0001 pounds and a share premium of about 0.1234 pounds on each share.

The company also proposed that the newly created capital reduction shares be canceled via a court-approved reduction of capital; and about 148.4 million pounds, being the amount standing to the credit of the company's share premium account following the capital reduction bonus Issue be canceled.

The company has scheduled an annual general meeting of shareholders on April 15. Following shareholder approval at the meeting, the proposed capital reduction would require court approval, which is expected to occur by the end of May.

The company's shares, which gained over 9% in Canada yesterday, gained 2.8% on last look on Tuesday. The stock fell 2% as at 4:35 pm GMT in London Stock Exchange trading on Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Citizens Financial Group Files Prospectus Supplement For Senior Notes
Citizens Financial Group Files Prospectus Supplement For Senior Notes
Jul 18, 2024
12:15 PM EDT, 07/18/2024 (MT Newswires) -- Citizens Financial Group ( CFG ) on Thursday filed a preliminary prospectus supplement for the offering of an undisclosed amount of fixed/floating rate senior notes. The company plans to use the proceeds for general corporate purposes, according to the filing. Barclays, Citigroup and Goldman Sachs are among the joint book-running managers. Price: 41.29,...
PNC Financial Services Files Prospectus Supplement for Debt Offering
PNC Financial Services Files Prospectus Supplement for Debt Offering
Jul 18, 2024
12:18 PM EDT, 07/18/2024 (MT Newswires) -- PNC Financial Services Group ( PNC ) on Thursday filed a prospectus supplement for the potential sale of fixed/floating rate senior notes due 2027 and 2035. The size and timing of the sale was not disclosed. The company expects to use the net proceeds for general corporate purposes. Price: 178.73, Change: -0.98, Percent...
Why Professional Services Company Equifax Shares Are Surging Today
Why Professional Services Company Equifax Shares Are Surging Today
Jul 18, 2024
Equifax Inc. ( EFX ) shares are surging today after the company reported better-than-expected second-quarter FY24 financial results. Revenue grew 9% Y/Y to $1.43 billion, beating the consensus of $1.42 billion. Despite a 13% decline in USIS mortgage credit inquiries, U.S. mortgage revenue grew by 4% Y/Y in the second quarter. In the second quarter, Workforce Solutions saw a 5% Y/Y increase...
Ardelyx, Groups File Lawsuit Over Dialysis Payment System Coverage
Ardelyx, Groups File Lawsuit Over Dialysis Payment System Coverage
Jul 18, 2024
12:19 PM EDT, 07/18/2024 (MT Newswires) -- Ardelyx ( ARDX ) said Thursday that it partnered with two groups in filing a lawsuit seeking to stop the Centers for Medicare and Medicaid Services from pursuing a plan to include Xphozah and other oral-only phosphate lowering therapies in the End-Stage Renal Disease Prospective Payment System beginning Jan. 1, 2025. Xphozah and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved